PHATHOM PHARMACEUTICALS, INC. (PHAT) Gross profit 2022–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual gross profit history from SEC filings — each fiscal year as reported.
$152.5MFY2025 · since FY2022: $0 → $152.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $152.5M | +222.6% |
| FY2024 | $47.3M | +9080.4% |
| FY2023 | $515,000 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net incomePHAT Net marginPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →